177 related articles for article (PubMed ID: 18847185)
41. Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.
Nakashima H; Uto Y; Nakata E; Nagasawa H; Ikkyu K; Hiraoka N; Nakashima K; Sasaki Y; Sugimoto H; Shiro Y; Hashimoto T; Okamoto Y; Asakawa Y; Hori H
Bioorg Med Chem; 2008 Sep; 16(18):8661-9. PubMed ID: 18715787
[TBL] [Abstract][Full Text] [Related]
42. Asymmetric synthesis of the core structure of leucosceptroids A-D.
Xie J; Ma Y; Horne DA
J Org Chem; 2011 Aug; 76(15):6169-76. PubMed ID: 21644513
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
[TBL] [Abstract][Full Text] [Related]
44. Click chemistry inspired synthesis and bioevaluation of novel triazolyl derivatives of osthol as potent cytotoxic agents.
Farooq S; Shakeel-u-Rehman ; Hussain A; Hamid A; Qurishi MA; Koul S
Eur J Med Chem; 2014 Sep; 84():545-54. PubMed ID: 25062005
[TBL] [Abstract][Full Text] [Related]
45. Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers.
Bonnet M; Hong CR; Gu Y; Anderson RF; Wilson WR; Pruijn FB; Wang J; Hicks KO; Hay MP
Bioorg Med Chem; 2014 Apr; 22(7):2123-32. PubMed ID: 24650701
[TBL] [Abstract][Full Text] [Related]
46. Tricyclic imidazole antagonists of the Neuropeptide S Receptor.
Trotter BW; Nanda KK; Manley PJ; Uebele VN; Condra CL; Gotter AL; Menzel K; Henault M; Stocco R; Renger JJ; Hartman GD; Bilodeau MT
Bioorg Med Chem Lett; 2010 Aug; 20(15):4704-8. PubMed ID: 20615693
[TBL] [Abstract][Full Text] [Related]
47. Complete 1H, 13C and 15N NMR assignment of tirapazamine and related 1,2,4-benzotriazine N-oxides.
Boyd M; Hay MP; Boyd PD
Magn Reson Chem; 2006 Oct; 44(10):948-54. PubMed ID: 16900565
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and antiproliferative activity of some novel benzo-fused imidazo[1,8]naphthyridinones.
Giannouli V; Kostakis IK; Pouli N; Marakos P; Samara P; Tsitsilonis O
Bioorg Med Chem Lett; 2015 Jul; 25(13):2621-3. PubMed ID: 25998504
[TBL] [Abstract][Full Text] [Related]
49. Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model.
Kyle AH; Minchinton AI
Cancer Chemother Pharmacol; 1999; 43(3):213-20. PubMed ID: 9923551
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins.
Denny WA; Atwell GJ; Roberts PB; Anderson RF; Boyd M; Lock CJ; Wilson WR
J Med Chem; 1992 Dec; 35(26):4832-41. PubMed ID: 1479583
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.
Tamiz AP; Smith MP; Kozikowski AP
Bioorg Med Chem Lett; 2000 Feb; 10(3):297-300. PubMed ID: 10698458
[TBL] [Abstract][Full Text] [Related]
52. Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine.
Hicks KO; Myint H; Patterson AV; Pruijn FB; Siim BG; Patel K; Wilson WR
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):560-71. PubMed ID: 17869669
[TBL] [Abstract][Full Text] [Related]
53. Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards.
Wilson WR; Hicks KO; Pullen SM; Ferry DM; Helsby NA; Patterson AV
Radiat Res; 2007 Jun; 167(6):625-36. PubMed ID: 17523848
[TBL] [Abstract][Full Text] [Related]
54. Fragmentation of the quinoxaline N-oxide bond to the ˙OH radical upon one-electron bioreduction.
Yadav P; Marshall AJ; Reynisson J; Denny WA; Hay MP; Anderson RF
Chem Commun (Camb); 2014 Nov; 50(89):13729-31. PubMed ID: 25248989
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
[TBL] [Abstract][Full Text] [Related]
56. Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).
Denny WA; Wilson WR
Cancer Metastasis Rev; 1993 Jun; 12(2):135-51. PubMed ID: 8375017
[TBL] [Abstract][Full Text] [Related]
57. Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase.
Smith L; Wong WC; Kiselyov AS; Burdzovic-Wizemann S; Mao Y; Xu Y; Duncton MA; Kim K; Piatnitski EL; Doody JF; Wang Y; Rosler RL; Milligan D; Columbus J; Balagtas C; Lee SP; Konovalov A; Hadari YR
Bioorg Med Chem Lett; 2006 Oct; 16(19):5102-6. PubMed ID: 16887347
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in mice.
Walton MI; Workman P
J Pharmacol Exp Ther; 1993 May; 265(2):938-47. PubMed ID: 8496834
[TBL] [Abstract][Full Text] [Related]
59. Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).
Watterson SH; Langevine CM; Van Kirk K; Kempson J; Guo J; Spergel SH; Das J; Moquin RV; Dyckman AJ; Nirschl D; Gregor K; Pattoli MA; Yang X; McIntyre KW; Yang G; Galella MA; Booth-Lute H; Chen L; Yang Z; Wang-Iverson D; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
Bioorg Med Chem Lett; 2011 Dec; 21(23):7006-12. PubMed ID: 22018461
[TBL] [Abstract][Full Text] [Related]
60. A ring-expansion approach to roseophilin.
Salamone SG; Dudley GB
Org Lett; 2005 Sep; 7(20):4443-5. PubMed ID: 16178554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
